0	10	Processing	processing	NN
11	13	of	of	IN
14	17	the	the	DT
18	27	precursor	precursor	NN
28	30	of	of	IN
31	39	NF-kappa	NF-kappa	NNP
40	41	B	B	NNP
42	44	by	by	IN
45	48	the	the	DT
49	54	HIV-1	HIV-1	NNP
55	63	protease	protease	NN
64	70	during	during	IN
71	76	acute	acute	JJ
77	86	infection	infection	NN
86	87	.	.	.

89	102	Transcription	transcription	NN
103	105	of	of	IN
106	109	the	the	DT
110	115	human	human	JJ
116	132	immunodeficiency	immunodeficiency	NN
133	138	virus	virus	NN
139	145	type-1	type-1	NN
146	147	(	(	(
147	152	HIV-1	HIV-1	NNP
152	153	)	)	)
154	160	genome	genome	NN
161	163	is	be	VBZ
164	173	regulated	regulate	VBN
174	176	in	in	IN
177	181	part	part	NN
182	184	by	by	IN
185	193	cellular	cellular	JJ
194	201	factors	factor	NNS
202	205	and	and	CC
206	208	is	be	VBZ
209	219	stimulated	stimulate	VBN
220	222	by	by	IN
223	233	activation	activation	NN
234	236	of	of	IN
237	245	latently	latently	RB
246	254	infected	infected	JJ
255	256	T	t	NN
257	262	cells	cell	NNS
262	263	.	.	.

264	270	T-cell	t-cell	NN
271	281	activation	activation	NN
282	286	also	also	RB
287	297	correlates	correlate	VBZ
298	302	with	with	IN
303	306	the	the	DT
307	316	induction	induction	NN
317	319	of	of	IN
320	323	the	the	DT
324	330	factor	factor	NN
331	339	NF-kappa	NF-kappa	NNP
340	341	B	B	NNP
342	347	which	which	WDT
348	353	binds	bind	VBZ
354	356	to	to	TO
357	360	two	two	CD
361	369	adjacent	adjacent	JJ
370	375	sites	site	NNS
376	378	in	in	IN
379	382	the	the	DT
383	388	HIV-1	HIV-1	NNP
389	393	long	long	JJ
394	402	terminal	terminal	JJ
403	409	repeat	repeat	NN
409	410	.	.	.

411	415	This	this	DT
416	422	factor	factor	NN
423	431	consists	consist	VBZ
432	434	of	of	IN
435	438	two	two	CD
439	450	DNA-binding	dna-binding	JJ
451	459	subunits	subunit	NNS
460	462	of	of	IN
463	471	relative	relative	JJ
472	481	molecular	molecular	JJ
482	486	mass	mass	NN
487	493	50,000	50,000	CD
494	495	(	(	(
495	498	50K	50k	CD
498	499	)	)	)
500	510	associated	associate	VBN
511	515	with	with	IN
516	519	two	two	CD
520	523	65K	65k	CD
524	532	subunits	subunit	NNS
532	533	.	.	.

534	536	It	it	PRP
537	539	is	be	VBZ
540	547	located	locate	VBN
548	550	in	in	IN
551	554	the	the	DT
555	562	nucleus	nucleus	NN
563	565	in	in	IN
566	572	mature	mature	JJ
573	574	B	B	NNP
575	580	cells	cell	NNS
580	581	,	,	,
582	585	but	but	CC
586	588	is	be	VBZ
589	596	present	present	JJ
597	599	in	in	IN
600	605	other	other	JJ
606	610	cell	cell	NN
611	616	types	type	NNS
617	619	as	as	IN
620	622	an	an	DT
623	631	inactive	inactive	JJ
632	643	cytoplasmic	cytoplasmic	JJ
644	651	complex	complex	NN
651	652	.	.	.

653	661	External	external	JJ
662	669	stimuli	stimulus	NNS
669	670	,	,	,
671	680	including	include	VBG
681	686	those	those	DT
687	691	that	that	WDT
692	700	activate	activate	VBP
701	702	T	t	NN
703	708	cells	cell	NNS
708	709	,	,	,
710	716	result	result	VBP
717	719	in	in	IN
720	727	nuclear	nuclear	JJ
728	741	translocation	translocation	NN
742	744	of	of	IN
745	751	active	active	JJ
752	760	NF-kappa	NF-kappa	NNP
761	763	B.	B.	NNP
764	767	The	the	DT
768	775	cloning	cloning	NN
776	778	of	of	IN
779	782	the	the	DT
783	796	complementary	complementary	JJ
797	800	DNA	dna	NN
801	804	for	for	IN
805	808	the	the	DT
809	812	50K	50k	NN
813	820	subunit	subunit	NN
821	827	helped	help	VBD
828	830	to	to	TO
831	839	identify	identify	VB
840	842	an	an	DT
843	854	exclusively	exclusively	RB
855	866	cytoplasmic	cytoplasmic	JJ
867	871	105K	105k	CD
872	881	precursor	precursor	NN
882	883	(	(	(
883	887	p105	p105	NN
887	888	)	)	)
889	890	(	(	(
890	894	V.B.	V.B.	NNP
894	895	,	,	,
896	900	P.K.	P.K.	NNP
901	904	and	and	CC
905	909	A.I.	A.I.	NNP
909	910	,	,	,
911	921	manuscript	manuscript	NN
922	931	submitted	submit	VBN
931	932	)	)	)
932	933	.	.	.

934	937	The	the	DT
938	948	expression	expression	NN
949	951	of	of	IN
952	958	active	active	JJ
959	967	NF-kappa	NF-kappa	NNP
968	969	B	B	NNP
970	975	might	might	MD
976	985	therefore	therefore	RB
986	990	also	also	RB
991	993	be	be	VB
994	1003	regulated	regulate	VBN
1004	1006	by	by	IN
1007	1010	the	the	DT
1011	1017	extent	extent	NN
1018	1020	of	of	IN
1021	1031	processing	processing	NN
1032	1034	of	of	IN
1035	1039	p105	p105	NN
1039	1040	.	.	.

1041	1048	Because	because	IN
1049	1054	HIV-1	HIV-1	NNP
1055	1063	requires	require	VBZ
1064	1070	active	active	JJ
1071	1079	NF-kappa	NF-kappa	NNP
1080	1081	B	B	NNP
1082	1085	for	for	IN
1086	1095	efficient	efficient	JJ
1096	1109	transcription	transcription	NN
1109	1110	,	,	,
1111	1113	we	we	PRP
1114	1120	tested	test	VBD
1121	1124	the	the	DT
1125	1131	effect	effect	NN
1132	1134	of	of	IN
1135	1140	HIV-1	HIV-1	NNP
1141	1150	infection	infection	NN
1151	1153	on	on	IN
1154	1157	the	the	DT
1158	1168	processing	processing	NN
1169	1171	of	of	IN
1172	1175	the	the	DT
1176	1181	human	human	JJ
1182	1186	105K	105k	CD
1187	1196	precursor	precursor	NN
1196	1197	.	.	.

1198	1200	We	we	PRP
1201	1205	show	show	VBP
1206	1210	here	here	RB
1211	1215	that	that	IN
1216	1219	the	the	DT
1220	1225	HIV-1	HIV-1	NNP
1226	1234	protease	protease	NN
1235	1238	can	can	MD
1239	1246	process	process	VB
1247	1251	p105	p105	NN
1252	1255	and	and	CC
1256	1265	increases	increase	VBZ
1266	1272	levels	level	NNS
1273	1275	of	of	IN
1276	1282	active	active	JJ
1283	1290	nuclear	nuclear	JJ
1291	1299	NF-kappa	NF-kappa	NNP
1300	1301	B	B	NNP
1302	1309	complex	complex	NN
1309	1310	.	.	.